PIPERACILLIN AND TAZOBACTAM- piperacillin sodium and tazobactam sodium injection, powder, for solution

Country: মার্কিন যুক্তরাষ্ট্র

ভাষা: ইংরেজি

সূত্র: NLM (National Library of Medicine)

সক্রিয় উপাদান:

PIPERACILLIN SODIUM (UNII: M98T69Q7HP) (PIPERACILLIN ANHYDROUS - UNII:9I628532GX), TAZOBACTAM SODIUM (UNII: UXA545ABTT) (TAZOBACTAM - UNII:SE10G96M8W)

থেকে পাওয়া:

Fresenius Kabi USA, LLC

INN (International Name):

PIPERACILLIN SODIUM

রচনা:

PIPERACILLIN ANHYDROUS 36 g in 180 mL

প্রশাসন রুট:

INTRAVENOUS

প্রেসক্রিপশন টাইপ:

PRESCRIPTION DRUG

থেরাপিউটিক ইঙ্গিত:

Piperacillin and tazobactam for injection is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below. Appendicitis (complicated by rupture or abscess) and peritonitis caused by β-lactamase producing isolates of Escherichia coli or the following members of the Bacteroides fragilis group: B. fragilis , B. ovatus , B. thetaiotaomicron , or B. vulgatus . The individual members of this group were studied in fewer than 10 cases. Uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses and ischemic/diabetic foot infections caused by β-lactamase producing isolates of Staphylococcus aureus . Postpartum endometritis or pelvic inflammatory disease caused by

পণ্য সারাংশ:

Piperacillin and Tazobactam for Injection is supplied in the following size: Product Code 304074, NDC 63323-304-74 Piperacillin and Tazobactam for Injection pharmacy bulk package bottles should be stored at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature] prior to reconstitution. This container closure is not made with natural rubber latex.

অনুমোদন অবস্থা:

Abbreviated New Drug Application

পণ্য বৈশিষ্ট্য

PIPERACILLIN AND TAZOBACTAM - PIPERACILLIN SODIUM AND TAZOBACTAM
SODIUM INJECTION,
POWDER, FOR SOLUTION
FRESENIUS KABI USA, LLC
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR
PIPERACILLIN AND TAZOBACTAM FOR INJECTION.
PIPERACILLIN AND TAZOBACTAM FOR INJECTION: PHARMACY BULK PACKAGE
BOTTLES
INITIAL U.S. APPROVAL: 1993
TO REDUCE THE DEVELOPMENT OF DRUG-RESISTANT BACTERIA AND MAINTAIN THE
EFFECTIVENESS OF PIPERACILLIN AND
TAZOBACTAM FOR INJECTION AND OTHER ANTIBACTERIAL DRUGS, PIPERACILLIN
AND TAZOBACTAM FOR INJECTION SHOULD BE
USED ONLY TO TREAT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO
BE CAUSED BY BACTERIA.
INDICATIONS AND USAGE
Piperacillin and Tazobactam for Injection is a combination
penicillin-class antibacterial and β-lactamase inhibitor indicated
for treatment of:
Intra-abdominal infections ( 1.1)
Skin and skin structure infections ( 1.2)
Female pelvic infections ( 1.3)
Community-acquired pneumonia ( 1.4)
Nosocomial pneumonia ( 1.5)
DOSAGE AND ADMINISTRATION
The usual daily dose of Piperacillin and Tazobactam for Injection for
adults is 3.375 g every six hours totaling 13.5 g
(12.0 g piperacillin/1.5 g tazobactam) ( 2.1)
Initial presumptive treatment of patients with nosocomial pneumonia
should start with Piperacillin and Tazobactam for
Injection at a dosage of 4.5 g every six hours plus an aminoglycoside,
totaling 18.0 g (16.0 g piperacillin/2.0 g
tazobactam). ( 2.2)
Dosage in patients with renal impairment (≤40 mL/min of CRCL) and
dialysis patients should be reduced, based on the
degree of actual renal function impairment. ( 2.3)
For children with appendicitis and/or peritonitis the recommended
Piperacillin and Tazobactam for Injection dosage is
100 mg piperacillin/12.5 mg tazobactam per kilogram of body weight,
every 8 hours in pediatric patients 9 months of
age and older. For pediatric patients 2 to 9 months of age, the
re